Platelet Activation in Chronic Inflammatory Skin Diseases

This study is not yet open for participant recruitment. (see Contacts and Locations)
Verified December 2012 by Meir Medical Center
Sponsor:
Information provided by (Responsible Party):
Meir Medical Center
ClinicalTrials.gov Identifier:
NCT01759693
First received: December 28, 2012
Last updated: January 2, 2013
Last verified: December 2012

December 28, 2012
January 2, 2013
February 2013
August 2013   (final data collection date for primary outcome measure)
Platelet activation [ Time Frame: 6 months ] [ Designated as safety issue: No ]
Platelet function will be assessed at enrollment
Same as current
Complete list of historical versions of study NCT01759693 on ClinicalTrials.gov Archive Site
Mean platelet volume [ Time Frame: 6 months ] [ Designated as safety issue: No ]
Mean platelet volume will be assessed at enrollment
Same as current
Not Provided
Not Provided
 
Platelet Activation in Chronic Inflammatory Skin Diseases
Not Provided

Platelets are blood cells that are important in coagulation of the blood. These cells have recently been shown to play a role in a number of other biologic processes, for example inflammation. In this study the investigators will determine the extent of platelet activation in people suffering from common chronic skin inflammation-urticaria and allergic dermatitis.

Not Provided
Observational
Observational Model: Case Control
Time Perspective: Prospective
Not Provided
Not Provided
Non-Probability Sample

Hospital clinic

  • Urticaria
  • Atopic Dermatitis
Procedure: Blood sampling
Blood sampling
  • Skin disease
    Patients with urticaria or atopic dermatitis
    Intervention: Procedure: Blood sampling
  • Control
    Healthy volunteers
    Intervention: Procedure: Blood sampling
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Not yet recruiting
80
October 2013
August 2013   (final data collection date for primary outcome measure)

Inclusion Criteria: Urticaria or atopic dermatitis -

Exclusion Criteria:Lack of informed consent

-

Both
18 Years to 75 Years
Yes
Israel
 
NCT01759693
0113, MMC 0113
No
Meir Medical Center
Meir Medical Center
Not Provided
Not Provided
Meir Medical Center
December 2012

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP